All manuscripts must be submitted through the journal’s dedicated online submission system. Authors are required to create an account before initiating submission. Registration can be completed using the following link: https://manuscriptflow.net/journal/sjms/register. Once registered, authors can log in via https://manuscriptflow.net/journal/sjms/login to upload their manuscripts, submit supplementary files, monitor the progress of their submission, and respond to editorial decisions. Each submission must represent original, unpublished work that is not under consideration elsewhere. The corresponding author holds primary responsibility for the integrity of the manuscript, ensuring that all co-authors meet authorship criteria and that the content is accurate and complete. For any pre-submission queries or technical issues, authors may contact the editorial office via email.
After submission, each manuscript undergoes a structured double blind peer-review process to ensure quality and fairness. Initially, the manuscript is screened within a short period to confirm that it meets the journal’s basic requirements. This includes verification of formatting, structural compliance, and relevance to the journal’s scope. A plagiarism check is conducted using advanced who have been asked to revise their manuscript must provide a detailed response addressing each reviewer's comment,n, while suitable manuscripts proceed to peer review. The journal follows a double-blind peer review system, where both the authors’ and reviewers’ identities are kept confidential. Each manuscript is evaluated by independent subject experts who assess its scientific validity, originality, and relevance. Based on the reviewers’ feedback, the editorial team makes a final decision, which may involve acceptance, revision, or rejection. Authors asked to revise their manuscript must provide a detailed response addressing each reviewer's comment, along with a clearly updated version of the manuscript.
To maintain transparency and fairness, the journal has strict policies regarding conflicts of interest. If a manuscript is submitted by a member of the editorial board, the review process is handled independently to avoid bias. Similarly, submissions involving senior editorial members are managed by alternate editors. Any potential conflicts between authors and reviewers are carefully addressed, and reviewers may be reassigned if necessary to ensure impartial evaluation.
Authors who believe that a decision has been made based on a misunderstanding or procedural error may submit a formal appeal. The appeal must clearly outline the reasons and provide supporting evidence. Appeals should be submitted within a limited timeframe and are reviewed independently by senior editorial members. The final decision following appeal review is considered binding.
Authors retain the copyright of their work while granting the publisher permission for dissemination. Articles are published under an open-access ( Attribution-NonCommercial 4.0 International)model, allowing readers to freely access and use the content for non-commercial purposes with proper attribution. Authors are also allowed to share and reuse their work for academic and educational purposes. Any commercial reuse requires prior permission from the publisher.
The journal is committed to maintaining the highest standards of research integrity. All submissions are screened for plagiarism before peer review. While similarity thresholds are considered, each manuscript is evaluated contextually to ensure proper citation and originality. Any form of plagiarism or unethical practice results in immediate rejection. If misconduct is discovered after publication, appropriate actions such as retraction and institutional notification are undertaken.
Research involving human participants must comply with internationally accepted ethical standards. Authors are required to provide evidence of ethical approval from an appropriate review board, along with confirmation that informed consent was obtained from participants. Patient confidentiality must be strictly maintained. Clinical trials must be registered in recognised public registries before participant enrollment, and the registration details must be included in the manuscript. The journal does not accept studies involving animal experimentation.
Authors must include a clear statement describing how the data supporting their study can be accessed. This may involve public repositories, supplementary files, or availability upon request. If data sharing is restricted, the reasons must be clearly stated.
SPJP Proceedings follows the authorship guidelines established by the International Committee of Medical Journal Editors (ICMJE). To be listed as an author, an individual must have made a meaningful and substantial contribution to the research work. This includes active involvement in the conceptualisation and design of the study, as well as participation in data acquisition, collection, analysis, or interpretation. In addition to contributing to the research itself, an author must also play a significant role in the intellectual development of the manuscript, either by drafting the original content or by critically revising it to enhance its scientific quality and accuracy.
All authors are required to give final approval to the version of the manuscript that is submitted for publication, ensuring that they agree with its content and conclusions. Furthermore, each author must accept responsibility for the integrity of the work, taking accountability for all aspects of the study and ensuring that any questions related to accuracy or ethical standards are appropriately addressed.
It is important to note that individuals who have contributed only in a limited capacity, such as providing general supervision, financial support, technical assistance, or editorial help, do not qualify for authorship. Such contributions should instead be recognised in the acknowledgements section. The corresponding author holds the responsibility of confirming that all listed co-authors meet the required criteria and that each has reviewed and approved the final manuscript before submission.
To ensure the integrity and stability of the scholarly record, the list of authors is considered final upon the completion of the manuscript submission to the SPJP Proceedings. The journal will only consider changes to the authorship list, such as additions, deletions, or reordering, in exceptional circumstances. Acceptable justifications include a documented, genuine error in the original list (e.g., an accidental omission), substantial changes in contributor roles that occurred during major revisions, or evidence that an individual did not meet the journal's authorship criteria. To request a change, the corresponding author must submit a formal request to the editorial office at em@spjpproceedings.com. This request must be signed or otherwise agreed to by all original authors and all newly proposed authors. It must include a detailed justification for the change and any supporting evidence, such as a reassessment of contributions. The editorial office will review the request and retain final, absolute discretion on whether to authorise any changes to the published authorship.
To maintain clarity and ensure a smooth and systematic review process, all manuscripts submitted to SPJP Proceedings must follow a well-defined structure arranged in a specific sequence. This format is mandatory for all article types unless stated otherwise. Authors are required to prepare a separate title page file for blinded review, which should include the full title of the manuscript, names of all authors along with their institutional affiliations, complete contact details of the corresponding author, and any necessary disclaimers. In addition, a cover letter must be submitted separately, addressed to the Editor-in-Chief, briefly introducing the manuscript, highlighting its importance, and confirming that it complies with all submission requirements.
To ensure clarity and support a systematic review process, all manuscripts submitted to SPJP Proceedings must follow a clearly defined structure in a specific sequential order. This format is mandatory for all article types unless otherwise stated.
1. Title Page (separate file for blinded review): The title page should include the full title of the manuscript, names of all authors, their institutional affiliations, complete contact details of the corresponding author, and any relevant disclaimers.
2. Cover Letter (separate file): A formal letter addressed to the Editor-in-Chief introducing the manuscript, highlighting its significance, and confirming compliance with all submission guidelines.
3. Abstract: A concise summary of the study. Authors should follow the required format (structured or unstructured) based on the specific article type.
4. Main Text: The main body of the manuscript should be organised into the following standard sections:
5. Acknowledgements: Recognises individuals or organisations who contributed to the work but do not meet authorship criteria.
6. Author Contributions: A clear statement outlining each author’s role in the study, preferably using a standardised system such as the CRediT taxonomy.
7. Conflict of Interest Disclosure: A declaration of any financial or personal relationships that could influence the work, or a statement confirming no conflicts.
8. Funding Statement: Details all sources of financial support, including grant numbers where applicable.
9. Ethical Approval Statement: Confirms approval from an Institutional Review Board or Ethics Committee and includes information on patient consent where required.
10. Data Availability Statement: Explains how the data supporting the study can be accessed, whether through repositories, supplementary materials, or upon request.
11. References: All cited sources must be listed in Vancouver/NLM style and numbered sequentially according to their first appearance in the text.
12. Figure Legends: A separate list of concise captions for all figures. High-resolution figure files must be submitted separately.
13. Tables: Each table should be presented on a separate page with a clear title and any necessary footnotes. Tables must be submitted in an editable format.
To maintain consistency and ensure a smooth peer review and production workflow, all manuscripts submitted to SPJP Proceedings must strictly follow the prescribed technical formatting guidelines. Failure to comply with these requirements may result in the manuscript being returned for correction prior to review. Authors are required to use Times New Roman font in 12-point size throughout the document, with the entire manuscript formatted in single line spacing. The page layout must include uniform margins of 1 inch (2.54 cm) on all sides, ensuring a clean and professional presentation.
All body text should be fully justified to enhance readability and maintain uniform alignment. Additionally, manuscripts must include continuous page numbering, preferably placed in the footer for easy reference during the review process. Special attention should also be given to figures and tables, which must be numbered sequentially in the order they are cited in the text (e.g., Fig. 1, Table 1, Fig. 2, Table 2), and each should be accompanied by a clear and concise descriptive caption. Adhering to these formatting standards helps streamline the editorial process and ensures uniformity across all published articles.
SPJP Proceedings publishes a wide range of scholarly articles to accommodate different types of research and academic contributions. Authors are expected to carefully choose the most appropriate article category for their work and strictly follow the specific requirements associated with each type.
An Original Research Article is intended for manuscripts that present novel findings derived from empirical studies or technological advancements. These articles should typically range between 2,000 and 4,500 words (excluding abstract and references) and must include a structured abstract of 250–300 words with headings such as Background, Objectives, Methods, Results, and Conclusion. The manuscript should follow the standard IMRaD format (Introduction, Materials and Methods, Results, Discussion, and Conclusion), include 15 to 50 references, and may contain up to 8 tables and figures combined.
A Review Article provides a comprehensive and critical overview of existing literature on a specific topic. These manuscripts generally range from 2,500 to 6,000 words and include an abstract of approximately 250 words, which may be structured or unstructured. The organisation is flexible but should present a clear synthesis of current knowledge, critical analysis, and future directions. Authors are expected to include 30 to 70 references, with a limit of 8 tables and/or figures.
A Systematic Review involves a rigorous and reproducible approach to identifying, evaluating, and synthesising relevant studies addressing a defined research question. These articles typically range between 3,000 and 7,000 words and require a structured abstract of around 300 words. The manuscript must follow PRISMA guidelines, include 40 to 100 references, and may incorporate up to 10 tables and figures, including a mandatory PRISMA flow diagram.
A Case Report focuses on a unique, rare, or educational clinical case that offers valuable insights to the medical community. These manuscripts should be between 1,000 and 2,500 words and include an unstructured abstract of 150–200 words. The structure generally consists of Introduction, Case Presentation, Discussion, and Conclusion. Authors must ensure written informed patient consent is obtained and clearly stated. The reference range is 8 to 20, with up to 5 tables and/or figures allowed.
A Case Series presents multiple related cases to highlight patterns, novel techniques, or emerging clinical observations. These manuscripts typically range from 1,500 to 3,500 words and require a structured abstract of 200–250 words. The structure usually includes Introduction, Case Descriptions, Comparative Analysis or Discussion, and Conclusion. Authors should include 15 to 30 references, with a maximum of 8 tables and/or figures.
A Technical Note is a short communication focusing on a new technique, methodological improvement, or preliminary findings. These articles are generally concise, ranging from 600 to 1,500 words. An abstract is optional but, if included, should not exceed 150 words. The manuscript should follow a brief structure consisting of Introduction, Description of the Technique or Method, and Applications or Discussion. Typically, 10 to 15 references are expected, along with up to 2 tables and/or figures.
A Letter to the Editor is a brief and focused communication, often written to comment on a recently published article or to address a specific issue of interest. These submissions should be between 300 and 800 words and do not require an abstract. The format is usually direct and concise, beginning with a reference to the article or topic being discussed. Authors may include 3 to 8 references, and only one table or figure is permitted if it is essential to support the content.
Before submitting, authors should ensure that all required documents are included, such as the cover letter, title page, manuscript file, figures, tables, and ethical approvals. It is also important to confirm that all authors have approved the submission and that references are correctly formatted.
Once a manuscript is accepted, it enters the production phase, which includes editing and formatting. Authors will receive a proof version for final review and must submit any corrections within a short timeframe. The article is then published online and later assigned to a specific issue.
The journal has a clear policy for correcting published content. Minor errors may be corrected quickly without formal notice, while significant issues may require official correction notices or retraction if necessary. Authors are encouraged to report any errors promptly.
SPJP Proceedings follows the Vancouver/NLM referencing style to ensure uniformity and accuracy in scholarly citations. Authors must present references in a clear and consistent manner, adhering to standard international guidelines. References should be numbered sequentially in the order in which they first appear in the text, and these numbers should be used consistently for citation throughout the manuscript. Journal titles must be abbreviated according to Index Medicus standards, and wherever available, Digital Object Identifiers (DOIs) should be included to enhance accessibility and traceability of sources. For online resources, authors must provide complete publication details along with the date of access to ensure transparency and reliability.
With regard to authorship listing, references with one to six authors must include all author names, while those with seven or more authors should list the first six followed by “et al.” This approach maintains clarity while ensuring brevity in citation formatting.
The following examples illustrate the correct format for different types of references. A journal article citation should include the authors, title, journal name (abbreviated), year, volume, issue, page range, and DOI if available. For example: Smith AB, Jones CD, Lee EF, et al. Diagnostic accuracy of ultra-high-resolution CT for pulmonary nodules. Radiol Imaging. 2024;12(3):145–152. doi:10.1007/s10278-024-00989-x.
For books, the format should include the authors, title, edition, place of publication, publisher, and year, as in: Webb WR, Higgins CB. Thoracic Imaging: Pulmonary and Cardiovascular Radiology. 3rd ed. Philadelphia, PA: Lippincott Williams Wilkins; 2023.
A book chapter citation must include the chapter author, chapter title, editors, book title, place of publication, publisher, year, and page range. For example: Miller FH. MRI of the liver. In: Gazelle GS, Saini S, Mueller PR, eds. Hepatobiliary and Pancreatic Radiology. New York, NY: Thieme; 2024:234–267.
For online resources, authors should include the organisation or author name, title of the document, version (if applicable), URL, publication date, and access date. For instance: National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 3.2024. Published March 15, 2024. Accessed December 11, 2024.
For any inquiries, authors may contact the editorial office through the following channels: